Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The hedge fund social media army really going back to pushing far flung criminal conspiracy theories while still pretending to be invested in what they claim to be a criminal enterprise?! These narratives are laughable.
Have a good one Maverick0408
The identity of any hedge funds or others engaged in spoofing NWBO stock will be disclosed after the MTD is denied and the parties engage in discovery. The yapping by Chris Brown, John Hempton and others have noticeably died down. Unfortunately, the paid hedge fund social media army thinks they are immune and have continued their work. Time will tell.
John (aka @John_Hempton),
— hoffmann6383 (@hoffmann6383) November 29, 2023
Can you let us know who your prime broker is at Bronte Capital? Recent court cases have made it clear that the customers of these brokers are discoverable through litigation if said customers were engaged in spoofing, an illegal form of share price… https://t.co/DsCcinJyXn pic.twitter.com/5eJlTiEmQC
➡️Derivative Lawsuit Update (Part 1 of 2)⬅️
— hoffmann6383 (@hoffmann6383) November 28, 2023
The Case: In re Northwest Biotherapeutics, Inc. Stockholder Litigation, Case No. 2022-0193-JTL, Chancery Court of the State of Delaware
Plaintiffs allege that $NWBO's Board of Directors and certain executives improperly granted… pic.twitter.com/Rbf3bPA04t
Speaking of history, I see yours is one of setting multiple fake nwbo sale deadlines and bouncing false narratives off of poor man so the conversation appears organic. But hey, look over there, right?!
Nonsense. Regulators don't play when people's lives are on the line. They won't let someone run a trial to experiment on people without any sort of chance said trial can be used for approval. This narrative is laughable. Regulators don't run a circus like you want to portray in your posts.
Have a good holiday Ex! You recall our bet that you conveniently forgot about for the last few months?! I just saw you recently saying no submission this year.
People can question the trial design all they want but we already have approval from the MHRA, the FDA and other such regulators. It's a pointless narrative the hedge fund social media continues to hammer away at to scare investors that don't realize this is a non issue.
External controls are the norm these days. Some doctors throw ethics out of the window and want thousands more GBM patients to die early deaths because the thousands before them wasn't enough. Fortunately, the regulatory bodies don't share this draconian view.
$NWBO
— hoffmann6383 (@hoffmann6383) April 21, 2023
External controls in oncology indications are the norm at the FDA. Period.
"Pivotal trials supporting oncology approvals were much more likely to use a historical control than nononcology approvals (13 [72.2%] vs 8 [14.0%]; P < .001)..."https://t.co/CPyohBztFI pic.twitter.com/ap41RUpvVb
Ha, yes. Ex is denying he made this bet, but after today's PR he might magically remember, yes, he did make this bet. 😉
What's the strategy Maverick0408? I see you're done with setting fake sale deadlines over and over. Moved on to repeating disappointment narratives ad nauseum?
I can look later today. that stuff is behind a crazy paywall from what I remember
oblivious comment.
Market Makers are responsible for their own trades and that of their customers. You can disagree all you want with federal court judges on an anonymous message board account but it's not going to change the thinking and rulings of federal court judges one iota.
have a good one LC!
📢Oral Argument Update📢$NWBO v. @citsecurities, et al, Case No 1:22-cv-10185-GHW-GWG
— hoffmann6383 (@hoffmann6383) November 17, 2023
The Spoofing Lawsuit
NWBO’s lawsuit alleges 2,849 episodes of spoofing $NWBO's stock over a five year period by market makers Canaccord Genuity LLC, Citadel Securities LLC, G1 Execution…
when the best defense is "I only robbed $94k from you", you're in trouble
fyi - if you read the summary or the transcript itself you would realize that the issue of how much exactly Defendant's profited is a battle for the experts to decide and plaintiffs (nwbo) are claiming much more than 94k in value and that isn't even considering NWBO sold 200m+ shares at depressed prices. This isnt just how much the bad guys profited but how much nwbo was damaged as a result of the bad guys actions. We haven't even begun to talk about punitive damages. What sort of punitive damages will deter this type of future behavior by defendants that profit billions? Billions in punitives? Hundreds of millions? Obviously, the tens of millions in fines havent worked as a deterrent. That is what a jury will be deciding. Punitive damages could come in at a few multiples of any actual damages.
Anyways, I'm sure the hedge fund social media army loves the narratives your misleading posts are pushing. Keep up the good work my friend.
I'm sure shorts are following this case because they have nothing to worry about ;)
Head of Bronte Capital:
Still short nwbo
— John_Hempton (@John_Hempton) November 18, 2023
Oral Argument Update - see below.
Overall, I thought it went really well for NWBO
📢Oral Argument Update📢$NWBO v. @citsecurities, et al, Case No 1:22-cv-10185-GHW-GWG
— hoffmann6383 (@hoffmann6383) November 17, 2023
The Spoofing Lawsuit
NWBO’s lawsuit alleges 2,849 episodes of spoofing $NWBO's stock over a five year period by market makers Canaccord Genuity LLC, Citadel Securities LLC, G1 Execution…
$NWBO
— hoffmann6383 (@hoffmann6383) November 16, 2023
Nov 16, 2023
New Streeterville Capital, LLC loan in the amount of $11,005,000
11-10-23 loan: https://t.co/hmmaY3mm0j
11-29-21 loan: https://t.co/BcyA8BGzC2
'21 loan:
☑️$15m
☑️8% interest
☑️22 month loan
☑️8 months no payments
☑️14 month amortization period…
Summary coming.
$NWBO
— hoffmann6383 (@hoffmann6383) November 16, 2023
📣11-14-23 Motion to Dismiss Oral Argument - summary coming📣
Northwest Biotherapeutics, Inc v. Canaccord Genuity, LLC, et al. (Case No: 1:22-cv-10185)
The oral argument transcript will be an interesting read. The defendants double down on their argument that 2,849… pic.twitter.com/rWeCz51vQT
Ex, your comment as to the failed endpoint is blatantly false. The endpoint was changed prior to unblinding. Further, the patients that were originally in the control and crossed over took DCVax-L. When you take DCVax-L you are no longer part of the control. I'd recommend people get their information from experts in the field versus anonymous online posters with agendas. Further information on this subject can be found at the below post. I didn't read past the bullshit I found in the first 2 sentences of this post.
$NWBO
— hoffmann6383 (@hoffmann6383) October 6, 2023
A few comments on why we have an ECA, per Dr. Liau.
37 minute mark.https://t.co/Qx29dboU0S
Dr. Musella: Can you compare the OS of those who did not get the vaccine upfront to those that got placebo and did not crossover?
Dr. Liau: There were few very few of them… pic.twitter.com/0SVuGKtkqw
Good stuff BB!
Good stuff. Thanks for sharing.
just asking to use a computer and exhibits during the oral arguments per local rules. Nothing interesting.
10q in a nutshell: We are on time with our November submission date.
$NWBO
— hoffmann6383 (@hoffmann6383) November 9, 2023
Q3 '23 10Q: https://t.co/xgHhcf4a1l
RA Submission
"The Company is now in the final stages of preparing an application to the U.K. regulatory authority for approval of DCVax-L. The Company is working with teams of specialized consultants on preparation of the…
A MRK and NWBO deal is still very much alive
What the Daiichi Sankyo & $MRK deal means for a potential $NWBO and $MRK deal
— hoffmann6383 (@hoffmann6383) November 9, 2023
Nothing.
I don't believe the Daiichi Sankyo deal with $MRK will have any effect on a potential $NWBO deal. $MRK has three strategic pillars. See Image 1.
1⃣ Immuno-Oncology
2⃣ Precision Oncology… pic.twitter.com/9dZjdjqjs5
It's rare you get a bench ruling. I wouldn't count on it. Especially for a MTD as complex as this one. It will be weeks or months before a ruling. If we get a ruling before end of year I'd be very happy.
I'm confident the MTD will be denied. I think it will happen quickly. Quickly in a legal sense is still weeks or months.
imo
The derivative lawsuit is going nowhere much like the prior nuisance lawsuits:
➡️$NWBO Derivative Lawsuit Update⬅️
— hoffmann6383 (@hoffmann6383) November 7, 2023
The Case: In re Northwest Biotherapeutics, Inc. Stockholder Litigation, Case No. 2022-0193-JTL, Chancery Court of the State of Delaware
Note: This is NOT the Market Maker case (with Citadel, etc.)
Quick Summary: Plaintiffs allege that…
If you repeat a lie enough maybe someone will believe you. It isn't going to change the facts though. Two comments to the misinformation you have on repeat.
1. The following post helps clear up a lot of the misinformation Exwannabe spreads. Please note the obvious, Exwannabe is a self admitted non investor in NWBO and a self described IT guru. Dr. Liau is a world renowned neurosurgeon and head of UCLA neurosurgery. Exwannabe is anonymous. Dr. Liau is not.
$NWBO
— hoffmann6383 (@hoffmann6383) October 6, 2023
A few comments on why we have an ECA, per Dr. Liau.
37 minute mark.https://t.co/Qx29dboU0S
Dr. Musella: Can you compare the OS of those who did not get the vaccine upfront to those that got placebo and did not crossover?
Dr. Liau: There were few very few of them… pic.twitter.com/0SVuGKtkqw
It's about time we see an update in the SoC. The attached diagram is how NICE recommends treating patients age 16 and older that have been diagnosed with nGBM.
$NWBO
— hoffmann6383 (@hoffmann6383) November 1, 2023
The attached diagram shows NICE's current recommendations for treatment of nGBM in the UK for patients age 16 and older. #DCVax-L (and combos) will be life changing for these patients
It's about time for an update to the SoChttps://t.co/EzNLmhpLrg pic.twitter.com/L0gqyPy01P
$NWBO
— hoffmann6383 (@hoffmann6383) November 1, 2023
When you do a search for the NICE recommended treatment options for rGBM you get the below results.
The UK needs more options for both nGBM and rGBM patients.
Approval of #DCVax-L can't happen soon enough. pic.twitter.com/92e3z1rcCl
NICE has formally adopted and implemented guidance to encourage the price reimbursement approval to align with the regulatory approval process. We've already seen this play out with real world examples and now formal guidance has been adopted along these lines. This bodes well for NWBO as we approach the MAA submission date.
$NWBO
— hoffmann6383 (@hoffmann6383) November 1, 2023
➡️Positive NICE Guidance Updates⬅️
NICE recently updated their guidance to speed up the price reimbursement approval process. This should help $NWBO realize revenue shortly after MHRA approval.
✅The updated NICE guidance applies starting today, November 1st, '23. See… pic.twitter.com/rhV5eApe0L
This sounds like the Defendant's lawyers in NWBO's spoofing case.
The paid shills news to protect that business model!
have a good one friend
great stuff bb!
Right! We shareholders shouldn't ask why NWBO is spoofed more than any stock on the market. We shouldn't ask why NWBO is the most active board on Ihub by a large margin. We shouldn't ask why NWBO attracts all sorts of white knights on every social media platform to warn us gullible retail about our bad investment choices. We should keep our head in the sand and accept the statements of every non invested individual and make our investment decisions based on said statements.
Amazing advice! I've never heard better advice. You're the best! Have a good one friend. by.
Likely another fake account by our friend @Legend431 with zero good intentions for nwbo shareholders. I confirmed with the real Mike Roach that this is fake. Please report this account. It appears this person is going after NWBO shareholders as most of his/her follows are of known nwbo longs.
https://twitter.com/ItsMike_Poarch
This in addition to his X accounts impersonating crash, myself and others.
Half the posts on ihub are from wolves. They are trying to infest twitter but it is more difficult.
Keep your eyes open. There are lots of people that want to do real harm to NWBO.
The person has supposedly sold nwbo holdings 5x and his alternate investments have a track record of performing horribly. Robotdroid might be the last person on the planet I'd take stock advice from. Him or LC2020. It's close.
This must be the 5th time you have sold NWBO to invest elsewhere. Psst - no one cares.
I love how the hedge fund social media army has given up on building any back stories to give themselves a false sense of credibility. They just launch into transparent attacks on NWBO.